PROCEPT BioRobotics Director MOLL FREDERIC H Buys 20,000 Shares at $39.26/Share
PorAinvest
viernes, 15 de agosto de 2025, 11:26 am ET1 min de lectura
PRCT--
The acquisition was reported through a SEC Form 4 filing, which provides detailed information about the transaction [1]. According to the filing, Moll directly owns 863,159 shares of the company following the purchase. The transaction was made at a weighted average price of $39.2569 per share, with individual prices ranging from $38.71 to $39.645 [2].
This investment by a high-ranking executive can be seen as a vote of confidence in the company's future performance. It is essential for investors to consider such insider transactions as they can provide insights into the company's prospects and management's confidence in its strategy.
Reference List:
[1] https://www.stocktitan.net/sec-filings/PRCT/form-4-procept-bio-robotics-corporation-insider-trading-activity-57590c11faee.html
[2] https://www.tradingview.com/news/tradingview:c734415568138:0-procept-biorobotics-corp-director-frederic-h-moll-acquires-20-000-shares/
PROCEPT BioRobotics Corp. recently announced that Director MOLL FREDERIC H has made a significant investment in the company by acquiring 20,000 shares at a price of $39.26 per share on August 13, 2025. This notable transaction reflects the Director's confidence in the company's prospects and demonstrates his commitment to the organization's long-term growth.
PROCEPT BioRobotics Corp. recently announced that Director MOLL FREDERIC H has made a significant investment in the company by acquiring 20,000 shares at a price of $39.26 per share on August 13, 2025. This notable transaction reflects the Director's confidence in the company's prospects and demonstrates his commitment to the organization's long-term growth.The acquisition was reported through a SEC Form 4 filing, which provides detailed information about the transaction [1]. According to the filing, Moll directly owns 863,159 shares of the company following the purchase. The transaction was made at a weighted average price of $39.2569 per share, with individual prices ranging from $38.71 to $39.645 [2].
This investment by a high-ranking executive can be seen as a vote of confidence in the company's future performance. It is essential for investors to consider such insider transactions as they can provide insights into the company's prospects and management's confidence in its strategy.
Reference List:
[1] https://www.stocktitan.net/sec-filings/PRCT/form-4-procept-bio-robotics-corporation-insider-trading-activity-57590c11faee.html
[2] https://www.tradingview.com/news/tradingview:c734415568138:0-procept-biorobotics-corp-director-frederic-h-moll-acquires-20-000-shares/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios